STAREE
STAtins in Reducing Events in the Elderly
The active follow up phase of the STAREE trial has now finished, and we are busy preparing the data for analysis. We look forward to sharing the results with our valued participants and GPs in the second half of 2026.
If you would like to speak with a STAREE representative, you are welcome to call 1800 770 664 and leave us a message, or please email us at staree@monash.edu and we will respond as soon as possible.
STAREE is a world first randomised controlled trial, conducted by Universities across Australia, studying the effects of statins on healthy ageing.
The STAREE study is proudly funded by public health research grants. To reduce influence and bias, we do not accept funding from pharmaceutical companies. STAREE findings may directly benefit current and future generations of Australians.
In partnership with:
-
About STAREE
STAREE is the world's first randomised controlled trial of statin therapy among apparently healthy elderly people living in the community.
-
-
For GPs
Find out about the research and how you can come on board as a co-investigator.
-
Clinical Trial Information
Learn about how clinical trials are run, and the important gaps in medical knowledge that they fill.
-
Statins
Statins are a class of cholesterol lowering drug that may reduce decline in physical and mental function as well as reducing the incidence of heart disease, stroke and dementia.
News highlights
-
Delays in Medication Delivery
Due to the on-going COVID pandemic there are delays in mail parcels being sent which may mean that you don't receive your new medication supply as quickly as usual.
-
COVID-19 and STAREE
The current situation with coronavirus COVID-19 is having a significant impact on our community and general practices. In response, we have put in place precautionary measures to protect our participants, healthcare staff at practices and STAREE staff to help slow the spread of COVID-19 in our community...